B+
Bull case
25%
Probability
Target price
$718.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
IDXX
IDEXX LaboratoriesCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The bull case rests on durable recurring CAG Diagnostics growth, increased testing per visit, continued installed-base expansion, and the higher 2026 outlook. Q2 execution provides strong primary-source support, but the forward thesis still depends on sustained utilization and customer adoption.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.2.
What can break
Analyst target count, detailed estimate revisions, options data, short interest, social sentiment, and post-earnings price-reaction attribution are unavailable.
Momentum
54
Value
53
Sentiment
53
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $596.00 · Bull $718.00 · Bear $480.00Analysis 2026-09-03; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $718.73
Why
Momentum54 · Δ7d +10.7
Value53 · Δ7d +0.2
Sentiment53 · Δ7d +1.0
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta +0.2.
Contradictions & invalidation
- • Analyst target count, detailed estimate revisions, options data, short interest, social sentiment, and post-earnings price-reaction attribution are unavailable.
- • Competition from animal-health companies, veterinary reference laboratories, and corporate hospital networks could pressure execution [#10-K-2026-02-20].
- • The bear case is that U.S.
Catalyst clock
2026-08-04
Q2 2026 results and higher FY2026 outlook
Lead driver: Value · See fundamentals
Momentum
54
8% active weight
Current posture
7d trendImproving
Δ7d
+10.7
Δ21d
+22.8
Value
53
47% active weight
Current posture
7d trendFlat
Δ7d
+0.2
Δ21d
-0.7
Sentiment
53
45% active weight
Current posture
7d trendSoftening
Δ7d
+1.0
Δ21d
-21.0
Why this grade
Composite grade C. Momentum 54.1 / Value 53.0 / Sentiment 52.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-03. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$596.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$480.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$44.15B
Beta
1.67
Shares Out
78.78M
P/E (TTM)
54.1
P/S (TTM)
13.07
P/FCF (TTM)
57.94
Rev YoY
+9.7%
EPS YoY
+17.5%
Gross Margin
+62.5%
Op Margin
+32.1%
Net Debt
$795.99M
Current Ratio
1.11
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data